News | April 12, 2026
EMA gives green light to warmer & simpler delivery rules for Wegovy injection
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The company says the platform offers improved manufacturability and functional advantages
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The nationwide campaign, running from April 9–23 highlights the first 1,000 days, nutrition, responsive caregiving and play-based learning as critical pillars for children
Subscribe To Our Newsletter & Stay Updated
